Royce & Associates’s Argan AGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.99M | Sell |
4,994
-31,486
| -86% | -$20.9M | 0.03% | 531 |
|
|
2026
Q1 | $19.9M | Sell |
36,480
-24,136
| -40% | -$9.84M | 0.2% | 143 |
|
|
2025
Q4 | $19M | Sell |
60,616
-25,176
| -29% | -$7.99M | 0.19% | 161 |
|
|
2025
Q3 | $23.2M | Buy |
85,792
+16,052
| +23% | +$3.68M | 0.23% | 136 |
|
|
2025
Q2 | $15.4M | Buy |
69,740
+20,898
| +43% | +$3.77M | 0.16% | 192 |
|
|
2025
Q1 | $6.41M | Sell |
48,842
-628
| -1% | -$87.6K | 0.07% | 395 |
|
|
2024
Q4 | $6.78M | Sell |
49,470
-82,480
| -63% | -$11.3M | 0.06% | 417 |
|
|
2024
Q3 | $13.4M | Sell |
131,950
-40,161
| -23% | -$3.18M | 0.12% | 239 |
|
|
2024
Q2 | $12.6M | Sell |
172,111
-8,753
| -5% | -$574K | 0.12% | 255 |
|
|
2024
Q1 | $9.14M | Buy |
180,864
+880
| +0.5% | +$41.3K | 0.08% | 352 |
|
|
2023
Q4 | $8.42M | Sell |
179,984
-14,100
| -7% | -$643K | 0.08% | 361 |
|
|
2023
Q3 | $8.83M | Sell |
194,084
-243
| -0.1% | -$10K | 0.09% | 325 |
|
|
2023
Q2 | $7.66M | Buy |
194,327
+34,000
| +21% | +$1.38M | 0.07% | 389 |
|
|
2023
Q1 | $6.49M | Buy |
160,327
+49,350
| +44% | +$1.94M | 0.06% | 425 |
|
|
2022
Q4 | $4.09M | Buy |
+110,977
| New | +$3.9M | 0.04% | 518 |
|
|
2022
Q2 | – | Sell |
-214,279
| Closed | -$8.7M | – | 937 |
|
|
2022
Q1 | $8.7M | Sell |
214,279
-151,221
| -41% | -$5.93M | 0.07% | 406 |
|
|
2021
Q4 | $14.1M | Buy |
365,500
+53,500
| +17% | +$2.24M | 0.11% | 298 |
|
|
2021
Q3 | $13.6M | Buy |
312,000
+32,000
| +11% | +$1.45M | 0.1% | 323 |
|
|
2021
Q2 | $13.4M | Buy |
280,000
+38,500
| +16% | +$1.92M | 0.09% | 372 |
|
|
2021
Q1 | $12.9M | Buy |
241,500
+47,000
| +24% | +$2.27M | 0.09% | 374 |
|
|
2020
Q4 | $8.65M | Sell |
194,500
-135,231
| -41% | -$6.07M | 0.07% | 417 |
|
|
2020
Q3 | $13.8M | Buy |
329,731
+50,694
| +18% | +$2.23M | 0.15% | 190 |
|
|
2020
Q2 | $13.2M | Buy |
279,037
+61,700
| +28% | +$2.36M | 0.15% | 193 |
|
|
2020
Q1 | $7.51M | Sell |
217,337
-300,497
| -58% | -$12.5M | 0.1% | 266 |
|
|
2019
Q4 | $20.8M | Sell |
517,834
-106,847
| -17% | -$4.11M | 0.19% | 145 |
|
|
2019
Q3 | $24.5M | Buy |
624,681
+31,051
| +5% | +$1.25M | 0.23% | 105 |
|
|
2019
Q2 | $24.1M | Sell |
593,630
-49,167
| -8% | -$2.3M | 0.22% | 110 |
|
|
2019
Q1 | $32.1M | Buy |
642,797
+2,917
| +0.5% | +$131K | 0.27% | 84 |
|
|
2018
Q4 | $24.2M | Buy |
639,880
+74,234
| +13% | +$3.14M | 0.22% | 110 |
|
|
2018
Q3 | $24.3M | Buy |
565,646
+53,783
| +11% | +$2.18M | 0.17% | 159 |
|
|
2018
Q2 | $21M | Buy |
511,863
+243,571
| +91% | +$9.5M | 0.15% | 197 |
|
|
2018
Q1 | $11.5M | Buy |
268,292
+181,305
| +208% | +$7.63M | 0.08% | 341 |
|
|
2017
Q4 | $3.91M | Buy |
86,987
+86,804
| +47,434% | +$5.17M | 0.03% | 662 |
|
|
2017
Q3 | $12K | Buy |
+183
| New | +$11.5K | ﹤0.01% | 1126 |
|
|
2016
Q4 | – | Sell |
-38,000
| Closed | -$2.25M | – | 1081 |
|
|
2016
Q3 | $2.25M | Buy |
+38,000
| New | +$1.86M | 0.01% | 772 |
|
Other funds holding AGX
LPC
Royce & Associates's AGX Position: Q2 2026 in Review
Royce & Associates reduced its Argan (AGX) stake by 86% in Q2 2026, selling an estimated $20.9M and leaving 4,994 shares worth $3.99M. The position accounts for 0.03% of the portfolio, ranked #531.
Royce & Associates first reported a position in AGX in Q3 2016 and has held it in 35 quarters since. The position peaked at $32.1M in Q1 2019. 562 funds tracked by Wall St. Rank hold AGX as of Q2 2026.
- Royce & Associates held 4,994 shares of Argan worth $3.99M as of Q2 2026.
- Royce & Associates sold 31,486 Argan shares in Q2 2026, an estimated $20.9M.
- Argan made up 0.03% of Royce & Associates's portfolio in Q2 2026, its #531 holding.
- Royce & Associates first reported a position in Argan in Q3 2016 and has held it in 35 quarters since.
- Royce & Associates's Argan position peaked at $32.1M in Q1 2019.
- 562 funds tracked by Wall St. Rank held Argan as of Q2 2026.
Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.